High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods J Quer, J Gregori, F Rodríguez-Frias, M Buti, A Madejon, ... Journal of clinical microbiology 53 (1), 219-226, 2015 | 108 | 2015 |
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers R López-Rodríguez, J Novalbos, S Gallego-Sandín, M Román-Martínez, ... Pharmacological research 58 (1), 77-84, 2008 | 94 | 2008 |
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers J Novalbos, R López-Rodríguez, M Román, S Gallego-Sandín, D Ochoa, ... Journal of clinical psychopharmacology 30 (5), 504-511, 2010 | 80 | 2010 |
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 72 | 2023 |
Effect of polymorphisms on the pharmacokinetics, pharmacodynamics and safety of sertraline in healthy volunteers M Saiz‐Rodríguez, C Belmonte, M Román, D Ochoa, D Koller, M Talegón, ... Basic & clinical pharmacology & toxicology 122 (5), 501-511, 2018 | 65 | 2018 |
Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects T Cabaleiro, R López‐Rodríguez, D Ochoa, M Román, J Novalbos, ... Human Psychopharmacology: Clinical and Experimental 28 (3), 205-214, 2013 | 65 | 2013 |
Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers T Cabaleiro, M Román, D Ochoa, M Talegón, R Prieto-Pérez, A Wojnicz, ... Drug Metabolism and Disposition 41 (1), 224-229, 2013 | 65 | 2013 |
Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human Molecular Genetics 31 (22), 3789-3806, 2022 | 55 | 2022 |
Lithium and venlafaxine interaction: a case of serotonin syndrome J Adan‐Manes, J Novalbos, R López‐Rodríguez, JL Ayuso‐Mateos, ... Journal of clinical pharmacy and therapeutics 31 (4), 397-400, 2006 | 49 | 2006 |
Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers T Cabaleiro, D Ochoa, R López‐Rodríguez, M Román, J Novalbos, ... Human Psychopharmacology: Clinical and Experimental 29 (5), 459-469, 2014 | 47 | 2014 |
CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment B Almoguera, R Riveiro-Alvarez, J Lopez-Castroman, P Dorado, ... Pharmacogenetics and genomics 23 (11), 627-630, 2013 | 43 | 2013 |
DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers R López-Rodríguez, M Román, J Novalbos, ML Pelegrina, D Ochoa, ... Journal of clinical psychopharmacology 31 (5), 555-562, 2011 | 41 | 2011 |
Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers AM Borobia, J Novalbos, P Guerra-López, R López-Rodríguez, B Tabares, ... Pharmacological research 59 (6), 393-398, 2009 | 40 | 2009 |
Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects T Cabaleiro, R López-Rodríguez, M Román, D Ochoa, J Novalbos, ... International clinical psychopharmacology 30 (2), 82-88, 2015 | 35 | 2015 |
Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C Y Rodríguez‐Muñoz, S Martín‐Vílchez, R López‐Rodríguez, ... Alimentary pharmacology & therapeutics 34 (8), 960-971, 2011 | 33 | 2011 |
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping JR Vidal-Castiñeira, A López-Vázquez, R Alonso-Arias, MA Moro-García, ... Journal of hepatology 56 (6), 1230-1238, 2012 | 32 | 2012 |
ATA homozigosity in the IL-10gene promoter is a risk factor for schizophrenia in Spanish females: a case control study B Almoguera, R Riveiro-Alvarez, J Lopez-Castroman, P Dorado, ... BMC Medical Genetics 12, 1-6, 2011 | 29 | 2011 |
High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease ME Soria, M Cortón, B Martínez-González, R Lobo-Vega, ... Access Microbiology 3 (9), 000259, 2021 | 27 | 2021 |
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population B Almoguera, R Riveiro-Alvarez, J López-Castromán, P Dorado, ... The Pharmacogenomics Journal 13 (2), 197-204, 2013 | 27 | 2013 |
Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: an exploratory study I Ortea, B Roschitzki, R López-Rodríguez, EG Tomero, JG Ovalles, ... PLoS One 11 (4), e0153140, 2016 | 26 | 2016 |